The Effect of Panax Notoginseng Powders on Rheumatic Pain

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of Panax Notoginseng Powders on Rheumatic Pain.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chengdu PLA General Hospital
• Treatments: Celecoxib

Criteria

Inclusion Criteria:

• had a diagnosis of classic or definite RA

• without conflict to the written, informed consent signed prior to the enrollment.

Exclusion Criteria:

• uncontrolled medical problems

• organic brain syndrome

• major psychiatric disturbances

• major communicative disorders

• a history of severe noncompliance

• less than 7 years of formal education, or illiteracy

• being included in other clinical trial within the last 4 weeks

• with abnormal liver or kidney function (more than 1 time above the high normal)

• with serious cardiovascular disease

• with hematologic disease

• being in pregnancy, lactation period or under a pregnancy plan

• with severe gastrointestinal disease

• with contraindication or being allergic to the test drugs

• being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as non-steroidal anti-inflammatory drugs

• being not compatible for the trial medication, or other circumstances at the discretion of investigators

• without legal capacity or only with limited legal capacity